Over the past 20 years the Clinical Research Division of the Fred Hutchinson Cancer Research Center has been involved in a continuing program of marrow transplantation for the treatment of patients with otherwise fatal malignant and nonmalignant hematological diseases. Initially, most transplants were with marrow from genotypically HLA-identical sibling donors. Over the past 5 years more and more grafts are being carried out with marrow from alternative donors including less-well-matched family members and unrelated individuals. Currently, approximately one-third of the transplants done here are from alternative donors. With the increasing use of alternative donors, the spectrum of transplant-related complications has changed. Graft failure and poor graft function have become prominent problems, as have acute graft-versus-host disease (GVHD), more severe and more frequent chronic GVHD, along with an increased incidence of bacterial infections. The current grant will address these complications due to the change in the selection of donors for marrow transplantation. Long-term follow-up, prevention and treatment of chronic GVHD, and infection prophylaxis will be addressed in Project 0002. Project 0011 will evaluate new protocols for immunization to encapsulated bacteria and define defects in production of lymphokines that regulated B-cell function. Project 0012 will analyze the selection process of immunoglobulin gene repertoire in B cells after transplantation. Three projects 0013, 0014, and 0015 will address the problem of graft failure, both in human marrow transplant recipients and in a preclinical canine model. In this context, stromal cell/marrow cell interactions will be investigated as well as the role of CD44 adhesion molecules in engraftment and that of class II antigens in stem cell proliferation and differentiation. Finally, preliminary in vitro studies on tolerance induction to major histocompatibility complex antigens by antibodies to CD3 will be extended in Project 0016 with the aim of developing novel ways for preventing GVHD in the setting of marrow grafts from alternative donors. A core section on information management, statistical, secretarial and administrative support completes the program project grant.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA018221-20
Application #
2086693
Study Section
Special Emphasis Panel (SRC (D1))
Project Start
1978-09-01
Project End
1996-11-30
Budget Start
1994-12-01
Budget End
1995-11-30
Support Year
20
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Mielcarek, Marco; Storer, Barry E; Boeckh, Michael et al. (2009) Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood 113:2888-94
Tseng, Li-Hui; Storer, Barry; Petersdorf, Effie et al. (2009) IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation. Transplantation 87:704-10
Bensinger, W I (2009) Role of autologous and allogeneic stem cell transplantation in myeloma. Leukemia 23:442-8
Bensinger, William (2008) Stem-cell transplantation for multiple myeloma in the era of novel drugs. J Clin Oncol 26:480-92
Storek, Jan (2008) Immunological reconstitution after hematopoietic cell transplantation - its relation to the contents of the graft. Expert Opin Biol Ther 8:583-97
Bensinger, William I (2007) Is there still a role for allogeneic stem-cell transplantation in multiple myeloma? Best Pract Res Clin Haematol 20:783-95
Carpenter, Paul A; Hoffmeister, Paul; Chesnut 3rd, Charles H et al. (2007) Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol Blood Marrow Transplant 13:683-90
Bensinger, William I (2007) Reduced intensity allogeneic stem cell transplantation in multiple myeloma. Front Biosci 12:4384-92
Bensinger, W I (2006) The current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma. Leukemia 20:1683-9
Zaucha, Renata E; Buckner, Dean C; Barnett, Todd et al. (2006) Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies. Int J Radiat Oncol Biol Phys 64:227-34

Showing the most recent 10 out of 692 publications